Professor Barnes trained in psychiatry in London and Cambridge, developing an interest in the psychopharmacology of schizophrenia. His research in schizophrenia and its treatment, which includes the West London first-episode study, the development of the Barnes Akathisia Rating Scale, and clinical trials of both pharmacological and psychological interventions, has generated over 300 publications. Current appointments include membership of the Royal College of Psychiatrists’ Psychopharmacology Special Committee and the MHRA Neurology, Pain & Psychiatry Expert Advisory Group. He is a past member of the Committee on Safety of Medicines, past President of the British Association for Psychopharmacology and has been a member of both NICE and BAP schizophrenia treatment guideline development groups. He is a co-editor of the latest edition of The Maudsley Prescribing Guidelines in Psychiatry.